Written by Dr. Roupen Odabashian MD, FRCPC. Oncologist | Founder, MeDucation AI | Updated September 2026
Quick Answer: Which Oncology Update Email Should You Use?
If you treat one disease and can write a solid PubMed search, a saved PubMed alert is free, exhaustive, and hard to beat. If you treat several cancers, want FDA approvals and guideline news in the same email as the literature, or do not want to maintain search strings, OncoPulse is the better fit, and it is also free. Journal table of contents emails and general newsletters are the weakest option for most clinicians because most of what they send is outside your field. Whatever you use, NCCN remains the place to confirm whether the standard of care changed.
Oncology Update Emails Compared: PubMed, Google Scholar, Journals, FDA, NCCN and OncoPulse
Option | What it covers | Filter by cancer type? | Removes repeats? | Setup effort | Cost | Verdict |
|---|---|---|---|---|---|---|
PubMed saved search alert | Indexed literature only | Yes, if you write the query | Within one search only | High (Boolean, MeSH) | Free | Best for one disease and skilled searchers |
Google Scholar alert | Broad literature, preprints, theses | Keyword only | No | Low | Free | Noisy; good as a backup |
Journal table of contents email | One journal's issue | No | Not applicable | Very low | Free | Low yield unless your field dominates the journal |
Publisher or society newsletters | News and conference coverage | Sometimes, by broad category | No | Low | Usually free | Good for headlines, variable depth |
FDA oncology approval notifications | New approvals and label changes | No | Not applicable | Very low | Free | Essential, but only one source type |
NCCN guideline updates | Standard of care changes | Yes, by guideline | Not applicable | Low | Free with registration | Essential for confirmation |
OncoPulse (MeDucation) | Research, clinical trials, FDA approvals, guideline articles | Yes, one schedule per topic | Yes, across everything it has sent | Low (pick topic, sources, days, time) | Free | Best for clinicians covering several cancers |
Why Most Oncology Literature Alerts and Update Emails Fail
Because the volume is enormous and most filters are either too broad or too narrow. PubMed indexed 156,059 cancer related articles in 2025, about 3,000 a week, including 5,713 clinical trial publications.[1][2] A journal table of contents email sends you a slice of that chosen by the journal, not by you. A keyword alert sends everything with the word in it. Either way, the email becomes something you archive unread.
The source types are also scattered. Literature lives in PubMed. Approvals live on the FDA site, which posted nine oncology and hematology approval notices between 31 July and 23 September 2026 alone.[3] Guideline changes live at NCCN, where every active guideline is reviewed at least yearly and interim updates happen whenever new data or approvals may change practice.[4] Staying current means checking all three, and most people do not.
PubMed Email Alerts for Oncology: When Are They the Best Choice?
When you treat one disease and know how to search. PubMed lets you create an email alert for any search through a free My NCBI account.[5] Its strengths are real: it pulls directly from the index, it is exhaustive for your query, and you control every term.
Limitations of PubMed Saved Search Alerts
Query quality is everything. A search for "colorectal cancer" returns far too much. A search tight enough to be useful needs MeSH terms, publication type filters, and maintenance when terminology shifts.
One source type. It will not tell you about an FDA approval or an NCCN revision.
No memory across alerts. If you build separate alerts for colon, rectal, and anal cancer, overlapping papers can arrive more than once.
For a researcher tracking one question, or an academic subspecialist with a well tuned query, a PubMed alert may be all you need for the literature.
What Is OncoPulse? A Free AI Agent for Oncology Updates
OncoPulse is a free AI agent that tracks the topics you choose and emails you only what is new and relevant. It was built for the clinician who is responsible for knowing what changed across several diseases and does not have time to maintain search strings.[6]
How to Set Up OncoPulse Email Alerts in Four Steps
Create a schedule for a topic. Each schedule is one topic, such as GI cancers, GU cancers, rectal cancer, or multiple myeloma. You can create one for every disease you treat.
Choose the sources. Published research, clinical trials, FDA approvals, and guideline articles. Keep all four or switch some off.
Choose the timing. Daily or on specific days of the week, at the delivery time you pick.
Read the email. Each schedule shows whether it is active and when the next update will arrive. Change topics, sources, days, or time whenever you like.
Example OncoPulse Setups for GI, GU, Community Oncology and Myeloma
Clinician | Schedule | Sources | Delivery |
|---|---|---|---|
GI oncologist | GI cancers | All four | Daily, 8 am |
GU oncologist | GU cancers | Research, trials, FDA approvals | Monday, Wednesday, Friday, 7 am |
Community oncologist | Breast; lung; GI; GU (four schedules) | FDA approvals and guidelines daily, research weekly | Staggered across the week |
Myeloma focused hematologist | Multiple myeloma | All four | Weekly, Sunday evening |
Beyond the filtering, two features matter in clinic. The agent does not resend items it has already sent. And updates include open clinical trials near you, which gives you a starting point when a patient asks whether there is a study for them.
OncoPulse is free for oncologists, hematologists, nurse practitioners, physician assistants, and fellows at meducationai.com/tutor/signup.
OncoPulse Limitations
It is a relevance filter, and every filter can miss something or surface something marginal. It is not a substitute for a formal systematic search, and it is not a substitute for reading the trial or the guideline before you change a treatment plan. Use it as the first pass that tells you where to look.
Are Journal Table of Contents Emails and Oncology Newsletters Worth Keeping?
Keep one or two, not ten. A general oncology journal's table of contents covers every disease site, so a GU oncologist will find most of each issue irrelevant. Publisher newsletters are good for headlines and conference coverage but vary in depth. If an email has gone unopened for a month, unsubscribe. Its signal is already coming from your filtered alert.
FDA Oncology Approval Notifications and NCCN Guideline Updates: Your Confirmation Layer
They are your confirmation layer. An alert tells you a phase 3 trial read out. The FDA page tells you whether the drug is on label for that indication. NCCN tells you whether the panel changed its recommendation. OncoPulse can fold FDA approvals and guideline related articles into your topic email, but for any decision that changes an order set, go to the source. Our guide on how to read the NCCN Guidelines explains how to read the "Updates" section quickly.
Oncology and Hematology Podcasts: What Email Alerts Can't Tell You
Email tells you what changed. Podcasts tell you what experts think it means, and they fit into time you already have. A cluster randomized trial across 27 US fellowship programs found that curated podcasts with show notes improved hematology oncology fellows' knowledge scores by 15.5 percentage points over didactics alone.[7]
The MeDucation Podcast Radio Station pairs naturally with OncoPulse. It organizes episodes by cancer topic, so you choose GU cancers, for example, and see the most recent GU episodes from leading shows like the ASCO and JCO podcasts, Oncology Brothers, and Two Onc Docs, reviewed by oncologists and hematologists. You can take notes while you listen, and they go straight into your Notebook. We compared the shows themselves in our roundup of the best oncology and hematology podcasts in 2026.
The Best Oncology Update Setup for Your Practice
If you... | Use |
|---|---|
Treat one disease and write strong searches | One PubMed alert, the FDA approvals page weekly, NCCN updates, one podcast |
Treat several diseases | One OncoPulse schedule per disease, NCCN updates, the Podcast Radio Station by topic |
Are a fellow | OncoPulse for your current rotation's disease, the Podcast Station for board topics, and a question bank to lock it in |
For fellows comparing clinical AI tools more broadly, see OpenEvidence vs UpToDate vs Doximity vs ChatGPT.
Frequently Asked Questions About Oncology Email Alerts
How do I get email alerts for new oncology research?
Two free options work well. Save a PubMed search and turn on an email alert through My NCBI, or set up an OncoPulse schedule for each cancer type you treat, choosing research, clinical trials, FDA approvals, and guideline articles and the days and time you want them.
Can I get oncology updates only for GI or GU cancers?
Yes. OncoPulse lets you create a separate schedule for each topic, such as GI cancers or GU cancers. With PubMed you would build a separate search for each disease.
Is OncoPulse better than a PubMed alert?
It depends on your practice. A PubMed alert is exhaustive and ideal for one disease if you can write a strong query. OncoPulse is better when you cover several cancers, want FDA and guideline news alongside the literature, or want an agent that does not repeat what it already sent.
How often does OncoPulse send emails?
You choose. Each schedule can be daily or on specific days of the week, at the delivery time you set, and you can change it at any time.
Does OncoPulse cost anything?
No. It is free for anyone caring for patients with cancer.
References
PubMed search: Neoplasms[MeSH] AND 2025[dp]. 156,059 results, accessed 24 September 2026. pubmed.ncbi.nlm.nih.gov
PubMed search: Neoplasms[MeSH] AND Clinical Trial[pt] AND 2025[dp]. 5,713 results, accessed 24 September 2026. pubmed.ncbi.nlm.nih.gov
U.S. Food and Drug Administration. Oncology (Cancer)/Hematologic Malignancies Approval Notifications. fda.gov
National Comprehensive Cancer Network. Development and Update of Guidelines. nccn.org
National Library of Medicine. PubMed User Guide: Create an email alert for a search. pubmed.ncbi.nlm.nih.gov/help
OncoDaily. Roupen Odabashian: If You Are Responsible for Knowing What Changed, OncoPulse Is Built for You. oncodaily.com
Patel VG, et al. Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial. JCO Oncol Pract. 2025. ascopubs.org
